vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.

Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $134.9M, roughly 1.8× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 10.6%, a 71.9% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 2.4%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 12.8%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.

CTRE vs TGLS — Head-to-Head

Bigger by revenue
TGLS
TGLS
1.8× larger
TGLS
$245.3M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+52.7% gap
CTRE
55.1%
2.4%
TGLS
Higher net margin
CTRE
CTRE
71.9% more per $
CTRE
82.5%
10.6%
TGLS
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
12.8%
TGLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
TGLS
TGLS
Revenue
$134.9M
$245.3M
Net Profit
$111.3M
$26.1M
Gross Margin
40.0%
Operating Margin
18.3%
Net Margin
82.5%
10.6%
Revenue YoY
55.1%
2.4%
Net Profit YoY
113.5%
-44.5%
EPS (diluted)
$0.52
$0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
TGLS
TGLS
Q4 25
$134.9M
$245.3M
Q3 25
$132.4M
$260.5M
Q2 25
$112.5M
$255.5M
Q1 25
$96.6M
$222.3M
Q4 24
$86.9M
$239.6M
Q3 24
$77.4M
$238.3M
Q2 24
$68.9M
$219.7M
Q1 24
$63.1M
$192.6M
Net Profit
CTRE
CTRE
TGLS
TGLS
Q4 25
$111.3M
$26.1M
Q3 25
$74.9M
$47.2M
Q2 25
$68.5M
$44.1M
Q1 25
$65.8M
$42.2M
Q4 24
$52.1M
$47.0M
Q3 24
$33.4M
$49.5M
Q2 24
$10.8M
$35.0M
Q1 24
$28.7M
$29.7M
Gross Margin
CTRE
CTRE
TGLS
TGLS
Q4 25
40.0%
Q3 25
42.7%
Q2 25
44.7%
Q1 25
43.9%
Q4 24
44.5%
Q3 24
45.8%
Q2 24
40.8%
Q1 24
38.8%
Operating Margin
CTRE
CTRE
TGLS
TGLS
Q4 25
18.3%
Q3 25
58.1%
25.1%
Q2 25
61.3%
24.0%
Q1 25
26.7%
Q4 24
28.0%
Q3 24
43.0%
28.4%
Q2 24
15.1%
23.3%
Q1 24
21.3%
Net Margin
CTRE
CTRE
TGLS
TGLS
Q4 25
82.5%
10.6%
Q3 25
56.6%
18.1%
Q2 25
60.9%
17.3%
Q1 25
68.1%
19.0%
Q4 24
60.0%
19.6%
Q3 24
43.2%
20.8%
Q2 24
15.6%
15.9%
Q1 24
45.6%
15.4%
EPS (diluted)
CTRE
CTRE
TGLS
TGLS
Q4 25
$0.52
$0.57
Q3 25
$0.35
$1.01
Q2 25
$0.35
$0.94
Q1 25
$0.35
$0.90
Q4 24
$0.30
$1.00
Q3 24
$0.21
$1.05
Q2 24
$0.07
$0.75
Q1 24
$0.22
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
TGLS
TGLS
Cash + ST InvestmentsLiquidity on hand
$198.0M
$104.1M
Total DebtLower is stronger
$894.2M
$174.4M
Stockholders' EquityBook value
$4.0B
$713.1M
Total Assets
$5.1B
$1.3B
Debt / EquityLower = less leverage
0.22×
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
TGLS
TGLS
Q4 25
$198.0M
$104.1M
Q3 25
$712.5M
$127.1M
Q2 25
$306.1M
$140.9M
Q1 25
$26.5M
$160.2M
Q4 24
$213.8M
$137.5M
Q3 24
$377.1M
$124.8M
Q2 24
$495.1M
$129.5M
Q1 24
$451.2M
$138.8M
Total Debt
CTRE
CTRE
TGLS
TGLS
Q4 25
$894.2M
$174.4M
Q3 25
$893.8M
$114.7M
Q2 25
$1.2B
$110.6M
Q1 25
$822.1M
$110.6M
Q4 24
$396.9M
$111.1M
Q3 24
$396.7M
$126.8M
Q2 24
$671.1M
$144.7M
Q1 24
$595.9M
$160.9M
Stockholders' Equity
CTRE
CTRE
TGLS
TGLS
Q4 25
$4.0B
$713.1M
Q3 25
$4.0B
$764.0M
Q2 25
$3.3B
$736.0M
Q1 25
$2.9B
$685.1M
Q4 24
$2.9B
$631.2M
Q3 24
$2.4B
$613.3M
Q2 24
$1.9B
$574.8M
Q1 24
$1.7B
$573.6M
Total Assets
CTRE
CTRE
TGLS
TGLS
Q4 25
$5.1B
$1.3B
Q3 25
$5.1B
$1.2B
Q2 25
$4.7B
$1.2B
Q1 25
$3.9B
$1.1B
Q4 24
$3.4B
$1.0B
Q3 24
$2.9B
$996.3M
Q2 24
$2.7B
$942.5M
Q1 24
$2.3B
$981.6M
Debt / Equity
CTRE
CTRE
TGLS
TGLS
Q4 25
0.22×
0.24×
Q3 25
0.22×
0.15×
Q2 25
0.35×
0.15×
Q1 25
0.28×
0.16×
Q4 24
0.14×
0.18×
Q3 24
0.16×
0.21×
Q2 24
0.35×
0.25×
Q1 24
0.36×
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
TGLS
TGLS
Operating Cash FlowLast quarter
$394.0M
$31.0M
Free Cash FlowOCF − Capex
$11.4M
FCF MarginFCF / Revenue
4.7%
Capex IntensityCapex / Revenue
8.0%
Cash ConversionOCF / Net Profit
3.54×
1.19×
TTM Free Cash FlowTrailing 4 quarters
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
TGLS
TGLS
Q4 25
$394.0M
$31.0M
Q3 25
$100.9M
$40.0M
Q2 25
$100.8M
$17.9M
Q1 25
$71.4M
$46.9M
Q4 24
$244.3M
$61.1M
Q3 24
$67.2M
$41.5M
Q2 24
$53.0M
$34.5M
Q1 24
$48.8M
$33.4M
Free Cash Flow
CTRE
CTRE
TGLS
TGLS
Q4 25
$11.4M
Q3 25
$21.2M
Q2 25
$-14.7M
Q1 25
$16.5M
Q4 24
$35.4M
Q3 24
$17.8M
Q2 24
$14.2M
Q1 24
$23.6M
FCF Margin
CTRE
CTRE
TGLS
TGLS
Q4 25
4.7%
Q3 25
8.2%
Q2 25
-5.7%
Q1 25
7.4%
Q4 24
14.8%
Q3 24
7.5%
Q2 24
6.5%
Q1 24
12.2%
Capex Intensity
CTRE
CTRE
TGLS
TGLS
Q4 25
8.0%
Q3 25
7.2%
Q2 25
12.7%
Q1 25
13.7%
Q4 24
10.7%
Q3 24
9.9%
Q2 24
9.2%
Q1 24
5.1%
Cash Conversion
CTRE
CTRE
TGLS
TGLS
Q4 25
3.54×
1.19×
Q3 25
1.35×
0.85×
Q2 25
1.47×
0.41×
Q1 25
1.08×
1.11×
Q4 24
4.68×
1.30×
Q3 24
2.01×
0.84×
Q2 24
4.92×
0.98×
Q1 24
1.70×
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

TGLS
TGLS

Product Sales$164.2M67%
Fixed Price Contracts$81.1M33%
Related Party$692.0K0%

Related Comparisons